Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

800496

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Continuing Care: Merseyside
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions he has had with (a) Southport and Formby CCG and (b) South Sefton CCG on (i) a moratorium on and (ii) funding for retrospective reviews of continuing healthcare; when funding will be available for retrospective claims and reviews in those CCG areas; and if he will make a statement.
tabling member constituency	Sefton Central
tabling member printed	Bill Esterson
uin	117117
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>The Secretary of State has not had discussions with Southport and Formby Clinical Commissioning Group (CCG) or South Sefton CCG about ‘retrospective reviews’ of NHS Continuing Healthcare, otherwise known as ‘previously unassessed periods of care’.</p><p> </p><p>Individuals, their families, or a representative are currently able to request an assessment from their responsible CCG for an NHS Continuing Healthcare ‘previously unassessed period of care’ for periods from 1 April 2012 onwards.</p><p> </p><p>In March 2012, deadlines were introduced for requests for an assessment for NHS Continuing Healthcare ‘previously unassessed periods of care’ between 1 April 2004 and 31 March 2012. The deadline for registering for a review of unassessed periods of care during this time period was 31 March 2013.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 07/12/2017 14:59:38 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4061 label Biography information for Bill Esterson

800500

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Scarlet Fever
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the reasons for the recent rise in scarlet fever cases across England.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	117121
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>Public Health England has undertaken detailed analysis of scarlet fever notifications in England and Wales, collected as part of the statutory notifications of infectious diseases, to understand the possible cause of the rise in scarlet fever cases. Assessment of strains collected from scarlet fever patients across England as part of this investigation ruled out the emergence of a new strain as the cause of this rise. Longitudinal assessment of notifications since 1911 identified periodic surges in disease but all of relatively smaller magnitude to that seen during this current resurgence. The assessment is available at:</p><p><a href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30693-X/fulltext?elsca1=tlpr" target="_blank">http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30693-X/fulltext?elsca1=tlpr</a></p><p>The data collected has shown that cases reported during the rise are similar to previous cases in terms of seasonal pattern of occurrence, demographic characteristics, and frequency of hospitalisation.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 15:13:24 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

800616

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Chronic Fatigue Syndrome
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, To ask the Secretary of State for Health, with reference to the report by Action for ME, Spotlight on specialist services: UK healthcare for people with ME, published in July 2017, what assessment his Department has made of the feasibility of collecting data on the prevalence of ME for each Clinical Commissioning Group area.
tabling member constituency	Leeds North West
tabling member printed	Alex Sobel
uin	117237
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>No assessment has been made.</p><p> </p><p>The National Institute for Health and Care Excellence reports that the annual estimated prevalence is at least 0.2–0.4% (around 190,000) in the United Kingdom. Population prevalence estimates, along with data on services usage and other local intelligence can support commissioners to deliver high quality services for the populations they serve.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 16:56:24 answering member 4067 label Biography information for Steve Brine
tabling member	4658 label Biography information for Alex Sobel

800673

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Leukaemia: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment he has made of the adequacy of the provision of treatment for people diagnosed with Juvenile Myelomonocytic Leukemia.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	117294
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>The usual treatment for juvenile myelomonocytic leukaemia is a stem cell transplant, the only type of treatment that can currently cure the disease. Unfortunately, this type of treatment is only suitable for some children. Currently NHS England commissions stem cell transplants from 12 providers across England. Doctors and scientists are trying to improve the treatment of this condition through both National Health Service funded and charitable means, however at this time it remains difficult to cure.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 16:58:14 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

800682

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Giant Cell Arteritis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent assessment he has made of the adequacy of provision of treatment for people diagnosed with Giant Cell Arteritis.
tabling member constituency	Coventry South
tabling member printed	Mr Jim Cunningham
uin	117303
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>Patients with Giant Cell Arteritis are covered by Specialised Rheumatology services which are organised into networks of care which include considering access to specialised drug therapies.</p><p> </p><p>The details of the NHS England service specification for Specialised Rheumatology which can be found on our website at:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a09/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/group-a/a09/</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 16:55:17 answering member 4067 label Biography information for Steve Brine
tabling member	308 label Biography information for Mr Jim Cunningham

800718

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drugs: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of drug use disorders on Disability-Adjusted Life Years lost in each region of England for each year for which data is available.
tabling member constituency	Vale of Clwyd
tabling member printed	Chris Ruane
uin	117339
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>There has been no formal assessment of disability adjusted life years lost through drug use disorders broken down by regional level.</p><p> </p><p>An assessment of years of life lost through drug use disorders is available in the publication Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. It assesses the scale of health lost from diseases and injuries in 2013, and estimates the attributable impact of risk factors; data for drug use disorders is included. This report does not include a regional assessment of Disability Adjusted Life Years. It was published on 15 September and is available at:</p><p><a href="https://www.gov.uk/government/publications/burden-of-disease-study-for-england" target="_blank">https://www.gov.uk/government/publications/burden-of-disease-study-for-england</a></p><p>This analysis was conceived and produced jointly by Public Health England and the Institute of Health Metrics and Evaluation, University of Washington.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 17:00:05 answering member 4067 label Biography information for Steve Brine
tabling member	534 label Biography information for Chris Ruane

800728

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	HIV Infection: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure the availability of Pre-Exposure Prophylaxis (PrEP) for people with HIV in areas of high HIV prevalence after the places on the PrEP impact trial are fully subscribed.
tabling member constituency	Canterbury
tabling member printed	Rosie Duffield
uin	117349
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>The planning assumptions that underpin the Pre-Exposure Prophylaxis (PrEP) IMPACT trial will offer a reasonable opportunity to participate to those assessed as meeting the eligibility criteria for the trial and willing to take PrEP. The availability of PrEP is in the context of a clinical trial with 10,000 participants which has been designed to answer important research questions to inform future commissioning and rollout plans. There will be opportunities as the trial progresses to consider re-allocating places between sites should it prove necessary to meet demand.</p><p> </p><p>Further information can be found on the PrEP IMPACT trial website at:</p><p><a href="http://www.prepimpacttrial.org.uk" target="_blank">www.prepimpacttrial.org.uk</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 15:06:45 answering member 4067 label Biography information for Steve Brine
tabling member	4616 label Biography information for Rosie Duffield

800769

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Commissioning Groups: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on how many occasions Care Commissioning Groups have paid a (a) financial settlement or (b) court award to an independent sector provider as a result of procurement and commissioning decisions, and if he will publish the Care Commissioning Groups and companies in each case.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	117390
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>NHS England has advised that under the terms of settlements agreed that parties are entitled to disclose only that an agreed resolution on the litigation has been reached and that these figures are confidential between the settling parties.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 117391 question first answered 07/12/2017 15:05:01 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

800770

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Commissioning Groups: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what the cost of litigation has been to Care Commissioning Groups regarding procurement and commissioning decisions in each of the last five years.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	117391
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>NHS England has advised that under the terms of settlements agreed that parties are entitled to disclose only that an agreed resolution on the litigation has been reached and that these figures are confidential between the settling parties.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 117390 question first answered 07/12/2017 15:05:01 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth

800771

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Virgin Care
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how much has been paid by (a) each of the six Surrey Care Commissioning Groups, (b) Surrey County Council, and (c) NHS England, to Virgin Care as a result of litigation relating to the procurement of children’s services in Surrey.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	117392
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>The subject matter of the litigation was resolved by a settlement agreement reached at mediation. Under the terms of the settlement agreed the parties are entitled to disclose only that an agreed resolution on the litigation concerning the Surrey children’s procurement has been reached to a satisfactory conclusion for all parties with detailed terms confidential to the parties.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 14:39:38 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth